| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000037952 |
| Receipt No. | R000043262 |
| Scientific Title | Baby Diaper Use Test |
| Date of disclosure of the study information | 2019/09/06 |
| Last modified on | 2019/11/26 (Ver. 7) |
| Basic information | ||
| Public title | Baby Diaper Use Test | |
| Acronym | Baby Diaper Use Test | |
| Scientific Title | Baby Diaper Use Test | |
| Scientific Title:Acronym | Baby Diaper Use Test | |
| Region |
|
|
| Condition | |||
| Condition | Healthy infants | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The influential comparative analysis exerted in the skin condition in the diaper for babies |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Comparison of the tetter score of target part after 1 week use of several kinds of diaper for babies |
| Key secondary outcomes | Use questionnaire and of skin picture after 1 week use of several kinds of diaper for babies |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Factorial |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 4 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | After using the sample diaper P for 1 week, subjects use the regular diaper for 1 week. | |
| Interventions/Control_2 | After using the sample diaper N for 1 week, subjects use the regular diaper for 1 week | |
| Interventions/Control_3 | After using the sample diaper P for 1 week, subjects use the sample diaper K for 1 week | |
| Interventions/Control_4 | After using the sample diaper N for 1 week, subjects use the sample diaper K for 1 week | |
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healthy infants | |||
| Key exclusion criteria | 1.The infant with chronic sickness.
2.The infant with the severe skin symptoms including the diaper rash. 3.The infant suffering from infectious diseases. 4.The infant who judged that the person in charge of a test in attendance is unsuitable as a test participant. |
|||
| Target sample size | 60 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | PT. INTAGE INDONESIA | ||||||
| Division name | Field Department | ||||||
| Zip code | 12430 | ||||||
| Address | Alamanda Tower 18th fl. Unit H, Jl. TB. Simatupang Kav. 23-24, Cilandak Barat, Jakarta 12430 | ||||||
| TEL | +62-21-2966-0070 | ||||||
| boy-hendarin@intage.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | PT. INTAGE INDONESIA | ||||||
| Division name | Customer Service Department | ||||||
| Zip code | 12430 | ||||||
| Address | Alamanda Tower 18th fl. Unit H, Jl. TB. Simatupang Kav. 23-24, Cilandak Barat, Jakarta 12430 | ||||||
| TEL | +62-21-2966-0070 | ||||||
| Homepage URL | |||||||
| nanami.watabe@intage.com | |||||||
| Sponsor | |
| Institute | PT. INTAGE INDONESIA |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Human Research Ethics Committee, Kao Corporation |
| Address | 2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN |
| Tel | +81-3-5630-9861 |
| morisaki.naoko@kao.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | PT. INTAGE INDONESIA |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 59 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043262 |